{"transactions":[{"id":727721,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T22:06:05.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":5277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the stock option vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date."}],"balance_after":5277,"derivative":{"exercise_price":68.92,"expiration_date":"2036-06-21","underlying":"Common Stock","underlying_shares":5277},"source":{"system":"sec-edgar","filing":"0001470831-26-000632","document":"wk-form4_1782338761.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000632/wk-form4_1782338761.xml","form_type":"4"}},{"id":727720,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T22:06:05.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":3990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":10579,"source":{"system":"sec-edgar","filing":"0001470831-26-000632","document":"wk-form4_1782338761.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000632/wk-form4_1782338761.xml","form_type":"4"}},{"id":739516,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T20:15:14.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":196299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":196299,"derivative":{"exercise_price":1.15,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":196299},"source":{"system":"sec-edgar","filing":"0001193125-26-269469","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000119312526269469/ownership.xml","form_type":"4"}},{"id":1102692,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T23:07:14.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":8425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the shares underlying the stock option will vest each year after June 20, 2025, such that all of the underlying shares will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":8425,"derivative":{"exercise_price":41.73,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":8425},"source":{"system":"sec-edgar","filing":"0000950170-25-089667","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000095017025089667/ownership.xml","form_type":"4"}},{"id":1102691,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T23:07:14.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":6589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan.  One-third of the RSUs will vest each year after June 20, 2025, such that all of the units will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":6589,"source":{"system":"sec-edgar","filing":"0000950170-25-089667","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000095017025089667/ownership.xml","form_type":"4"}},{"id":1111346,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:15:18.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":91970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":91970,"derivative":{"exercise_price":2.5,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":91970},"source":{"system":"sec-edgar","filing":"0000950170-25-086191","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000095017025086191/ownership.xml","form_type":"4"}},{"id":1469553,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-25T21:34:30.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":26014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares underlying the stock option will vest each year after June 21, 2024, such that all of the underlying shares will be vested on June 21, 2027, subject to the Reporting Person's continued service on the board of directors of the Issuer."}],"balance_after":26014,"derivative":{"exercise_price":27.36,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":26014},"source":{"system":"sec-edgar","filing":"0000950170-24-077437","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000095017024077437/ownership.xml","form_type":"4"}},{"id":1480404,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T20:30:07.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":51025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":51025,"derivative":{"exercise_price":4.63,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":51025},"source":{"system":"sec-edgar","filing":"0000950170-24-073068","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000095017024073068/ownership.xml","form_type":"4"}},{"id":1845280,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T20:14:24.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":51501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":51501,"derivative":{"exercise_price":16.75,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":51501},"source":{"system":"sec-edgar","filing":"0001209191-23-039342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919123039342/doc4.xml","form_type":"4"}},{"id":1851854,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T21:00:48.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":6989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":6989,"derivative":{"exercise_price":38.9,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":6989},"source":{"system":"sec-edgar","filing":"0000950170-23-028668","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000095017023028668/ownership.xml","form_type":"4"}},{"id":1910066,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-01T20:14:52.000Z","date":"2023-04-27","kind":"grant","planned":false,"acquired":true,"shares":28901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests in twelve equal monthly installments starting from April 27, 2023, subject to continued service with the Issuer through the applicable vesting dates."}],"balance_after":28901,"derivative":{"exercise_price":1.36,"expiration_date":"2033-04-27","underlying":"Common Stock","underlying_shares":28901},"source":{"system":"sec-edgar","filing":"0000899243-23-011928","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924323011928/doc4.xml","form_type":"4"}},{"id":1910065,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-01T20:14:52.000Z","date":"2023-04-27","kind":"grant","planned":false,"acquired":true,"shares":70422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issuable upon settlement of a restricted stock unit award that vests in full on May 15, 2024, subject to continued service with the Issuer through the vesting date."}],"balance_after":125322,"source":{"system":"sec-edgar","filing":"0000899243-23-011928","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924323011928/doc4.xml","form_type":"4"}},{"id":2221933,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T21:09:50.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":23867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":23867,"derivative":{"exercise_price":10.2,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":23867},"source":{"system":"sec-edgar","filing":"0000899243-22-024053","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924322024053/doc4.xml","form_type":"4"}},{"id":2222110,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:23:41.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":104921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares underlying the option will vest on June 22, 2023; thereafter, 1/3rd of the remaining underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on the June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":104921,"derivative":{"exercise_price":8.45,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":104921},"source":{"system":"sec-edgar","filing":"0001209191-22-039225","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919122039225/doc4.xml","form_type":"4"}},{"id":2286340,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-02T20:43:17.000Z","date":"2022-04-28","kind":"grant","acquired":true,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents Board Chair compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests in twelve equal monthly installments starting from April 28, 2022."}],"balance_after":5700,"derivative":{"exercise_price":5.22,"expiration_date":"2032-04-28","underlying":"Common Stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0000899243-22-016133","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924322016133/doc4.xml","form_type":"4"}},{"id":2286339,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-02T20:43:17.000Z","date":"2022-04-28","kind":"grant","acquired":true,"shares":16100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests in twelve equal monthly installments starting from April 28, 2022."}],"balance_after":16100,"derivative":{"exercise_price":5.22,"expiration_date":"2032-04-28","underlying":"Common Stock","underlying_shares":16100},"source":{"system":"sec-edgar","filing":"0000899243-22-016133","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924322016133/doc4.xml","form_type":"4"}},{"id":2286338,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-02T20:43:17.000Z","date":"2022-04-28","kind":"grant","acquired":true,"shares":11300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issuable upon settlement of a restricted stock unit award that vests in full on May 15, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents Board Chair compensation."}],"balance_after":54900,"source":{"system":"sec-edgar","filing":"0000899243-22-016133","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924322016133/doc4.xml","form_type":"4"}},{"id":2286337,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-02T20:43:17.000Z","date":"2022-04-28","kind":"grant","acquired":true,"shares":32100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issuable upon settlement of a restricted stock unit award that vests in full on May 15, 2023."}],"balance_after":43600,"source":{"system":"sec-edgar","filing":"0000899243-22-016133","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924322016133/doc4.xml","form_type":"4"}},{"id":2658952,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-22T22:45:15.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":38895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in three annual installments after June 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date."}],"balance_after":38895,"derivative":{"exercise_price":62.63,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":38895},"source":{"system":"sec-edgar","filing":"0000899243-21-025359","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924321025359/doc4.xml","form_type":"4"}},{"id":2729804,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-04T21:38:31.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents Board Chair compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests in twelve equal monthly installments starting from April 30, 2021."}],"balance_after":1500,"derivative":{"exercise_price":34.9,"expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0000899243-21-018203","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924321018203/doc4.xml","form_type":"4"}},{"id":2729803,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-04T21:38:31.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":4400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests in twelve equal monthly installments starting from April 30, 2021."}],"balance_after":4400,"derivative":{"exercise_price":34.9,"expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":4400},"source":{"system":"sec-edgar","filing":"0000899243-21-018203","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924321018203/doc4.xml","form_type":"4"}},{"id":2729802,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-04T21:38:31.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issuable upon settlement of a restricted stock unit award that vests in full on May 15, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents Board Chair compensation."}],"balance_after":11500,"source":{"system":"sec-edgar","filing":"0000899243-21-018203","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924321018203/doc4.xml","form_type":"4"}},{"id":2729801,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-04T21:38:31.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issuable upon settlement of a restricted stock unit award that vests in full on May 15, 2022."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0000899243-21-018203","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924321018203/doc4.xml","form_type":"4"}},{"id":2744929,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-19T23:52:05.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":28911,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option vest in equal monthly installments over a three year period beginning on April 20, 2021, so that all shares shall have vested on April 20, 2024, subject to the Reporting Person continued service to the Issuer through each vesting date."}],"balance_after":28911,"derivative":{"exercise_price":17,"expiration_date":"2031-04-14","underlying":"Common Stock","underlying_shares":28911},"source":{"system":"sec-edgar","filing":"0000899243-21-016301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924321016301/doc4.xml","form_type":"4"}},{"id":2937617,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-19T02:30:01.000Z","date":"2020-05-02","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was fully vested on May 2, 2020."}],"balance_after":0,"derivative":{"exercise_price":24.16,"expiration_date":"2029-05-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-20-034578","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924320034578/doc4.xml","form_type":"4"}},{"id":2937616,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-19T02:30:01.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":3600,"price":51.4667,"value":185280.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales of common stock were effected pursuant to a Rule 10b-5 sales plan adopted by the reporting person on August 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sale price. Actual sale prices ranged from $51.33 to $51.81 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-034578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924320034578/doc4.xml","form_type":"4"}},{"id":2937615,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-19T02:30:01.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":6400,"price":50.738,"value":324723.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales of common stock were effected pursuant to a Rule 10b-5 sales plan adopted by the reporting person on August 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sale price. Actual sale prices ranged from $50.30 to $51.29 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."}],"balance_after":3600,"source":{"system":"sec-edgar","filing":"0000899243-20-034578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924320034578/doc4.xml","form_type":"4"}},{"id":2937614,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-19T02:30:01.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":10000,"price":24.16,"value":241600.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-20-034578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924320034578/doc4.xml","form_type":"4"}},{"id":2974848,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-19T01:06:04.000Z","date":"2020-11-16","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option was fully vested on May 2, 2018."}],"balance_after":0,"derivative":{"exercise_price":11.13,"expiration_date":"2027-05-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001501134-20-000081","document":"wf-form4_160574794978058.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000150113420000081/wf-form4_160574794978058.xml","form_type":"4"}},{"id":2974847,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-19T01:06:04.000Z","date":"2020-11-16","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was fully vested on May 5, 2017."}],"balance_after":0,"derivative":{"exercise_price":9.18,"expiration_date":"2026-05-05","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001501134-20-000081","document":"wf-form4_160574794978058.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000150113420000081/wf-form4_160574794978058.xml","form_type":"4"}},{"id":2974846,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-19T01:06:04.000Z","date":"2020-11-16","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was fully vested on February 11, 2016."}],"balance_after":0,"derivative":{"exercise_price":8.51,"expiration_date":"2025-11-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001501134-20-000081","document":"wf-form4_160574794978058.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000150113420000081/wf-form4_160574794978058.xml","form_type":"4"}},{"id":2974845,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T01:06:04.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":7117,"price":47.05,"value":334854.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales of common stock were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.82 to $47.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001501134-20-000081","document":"wf-form4_160574794978058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000150113420000081/wf-form4_160574794978058.xml","form_type":"4"}},{"id":2974844,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T01:06:04.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":22883,"price":46.36,"value":1060855.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales of common stock were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.82 to $46.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":7117,"source":{"system":"sec-edgar","filing":"0001501134-20-000081","document":"wf-form4_160574794978058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000150113420000081/wf-form4_160574794978058.xml","form_type":"4"}},{"id":2974843,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T01:06:04.000Z","date":"2020-11-16","kind":"exercise","acquired":true,"shares":10000,"price":11.13,"value":111300.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001501134-20-000081","document":"wf-form4_160574794978058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000150113420000081/wf-form4_160574794978058.xml","form_type":"4"}},{"id":2974842,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T01:06:04.000Z","date":"2020-11-16","kind":"exercise","acquired":true,"shares":10000,"price":9.18,"value":91800.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001501134-20-000081","document":"wf-form4_160574794978058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000150113420000081/wf-form4_160574794978058.xml","form_type":"4"}},{"id":2974841,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T01:06:04.000Z","date":"2020-11-16","kind":"exercise","acquired":true,"shares":10000,"price":8.51,"value":85100.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001501134-20-000081","document":"wf-form4_160574794978058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000150113420000081/wf-form4_160574794978058.xml","form_type":"4"}},{"id":3081574,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-16T22:50:52.000Z","date":"2020-07-15","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was fully vested on June 22, 2019."}],"balance_after":0,"derivative":{"exercise_price":8.08,"expiration_date":"2028-06-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-20-019412","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924320019412/doc4.xml","form_type":"4"}},{"id":3081573,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-16T22:50:52.000Z","date":"2020-07-15","kind":"sale","acquired":false,"shares":6829,"price":34.2384,"value":233814.0336,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales of common stock were effected pursuant to a Rule 10b-5 sales plan adopted by the reporting person on August 8, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sale price. Actual sale prices ranged from $33.77 to $34.55 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-019412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924320019412/doc4.xml","form_type":"4"}},{"id":3081572,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-16T22:50:52.000Z","date":"2020-07-15","kind":"sale","acquired":false,"shares":3171,"price":33.4403,"value":106039.1913,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales of common stock were effected pursuant to a Rule 10b-5 sales plan adopted by the reporting person on August 8, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sale price. Actual sale prices ranged from $32.76 to $33.75 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."}],"balance_after":6829,"source":{"system":"sec-edgar","filing":"0000899243-20-019412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924320019412/doc4.xml","form_type":"4"}},{"id":3081571,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-16T22:50:52.000Z","date":"2020-07-15","kind":"exercise","acquired":true,"shares":10000,"price":8.08,"value":80800.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-20-019412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924320019412/doc4.xml","form_type":"4"}},{"id":3122269,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-04T23:11:08.000Z","date":"2020-06-02","kind":"grant","acquired":true,"shares":112422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in three annual installments after June 2, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date."}],"balance_after":112422,"derivative":{"exercise_price":29,"expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":112422},"source":{"system":"sec-edgar","filing":"0000899243-20-015297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320015297/doc4.xml","form_type":"4"}},{"id":3130768,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-29T16:08:21.000Z","date":"2020-05-27","kind":"grant","acquired":true,"shares":21528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in a single installment on the earlier of (i) the first anniversary of the grant date, so that all of the underlying shares shall be vested on May 26, 2021, or (ii) the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service with the Issuer through the vesting date.  This option is subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2018 Stock Option and Incentive Plan, as amended)."}],"balance_after":21528,"derivative":{"exercise_price":48.51,"expiration_date":"2030-05-27","underlying":"Common Stock","underlying_shares":21528},"source":{"system":"sec-edgar","filing":"0000899243-20-014544","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924320014544/doc4.xml","form_type":"4"}},{"id":3165258,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-02T00:41:54.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve equal monthly installments starting from April 30, 2020."}],"balance_after":20000,"derivative":{"exercise_price":16.55,"expiration_date":"2030-04-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-20-011775","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924320011775/doc4.xml","form_type":"4"}},{"id":3303050,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-01-24T18:43:42.000Z","date":"2020-01-22","kind":"exercise","acquired":false,"shares":771,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option, representing a right to purchase a total of 30,000 shares was granted on November 20, 2018, vesting in four equal installments on November 20, 2019, 2020, 2021 and 2022, subject to the option holder's continuous service with the Issuer at each vesting date. The optionholder previously exercised the option with respect to 6,729 shares on November 20, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"This employee stock option is held by the Reporting Person's spouse."}],"balance_after":22500,"derivative":{"exercise_price":32.42,"expiration_date":"2028-11-19","underlying":"Common Shares","underlying_shares":771},"source":{"system":"sec-edgar","filing":"0001562180-20-000570","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/primarydocument.xml","form_type":"4"}},{"id":3303049,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-01-24T18:43:42.000Z","date":"2020-01-22","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option, representing a right to purchase a total of 5,000 shares was granted on September 5, 2017, vesting in four equal installments on September 5, 2018, 2019, 2020 and 2021, subject to the option holder's continuous service with the Issuer at each vesting date. The optionholder previously exercised the option with respect to 1,250 shares on November 22, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"This employee stock option is held by the Reporting Person's spouse."}],"balance_after":2500,"derivative":{"exercise_price":37.54,"expiration_date":"2027-09-04","underlying":"Common Shares","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001562180-20-000570","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/primarydocument.xml","form_type":"4"}},{"id":3303048,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-01-24T18:43:42.000Z","date":"2020-01-22","kind":"sale","acquired":false,"shares":150,"price":58.8573,"value":8828.595,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.70 - $59.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001562180-20-000570","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/primarydocument.xml","form_type":"4"}},{"id":3303047,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-01-24T18:43:42.000Z","date":"2020-01-22","kind":"sale","acquired":false,"shares":200,"price":57.995,"value":11599.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.70 - $58.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":1400,"source":{"system":"sec-edgar","filing":"0001562180-20-000570","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/primarydocument.xml","form_type":"4"}},{"id":3303046,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-01-24T18:43:42.000Z","date":"2020-01-22","kind":"sale","acquired":false,"shares":671,"price":56.9943,"value":38243.1753,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.41 - $57.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":1600,"source":{"system":"sec-edgar","filing":"0001562180-20-000570","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/primarydocument.xml","form_type":"4"}},{"id":3303045,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-01-24T18:43:42.000Z","date":"2020-01-22","kind":"sale","acquired":false,"shares":500,"price":55.991,"value":27995.5,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.39 - $56.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2271,"source":{"system":"sec-edgar","filing":"0001562180-20-000570","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/primarydocument.xml","form_type":"4"}},{"id":3303044,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-01-24T18:43:42.000Z","date":"2020-01-22","kind":"sale","acquired":false,"shares":500,"price":54.9717,"value":27485.85,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.38 - $55.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2771,"source":{"system":"sec-edgar","filing":"0001562180-20-000570","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/primarydocument.xml","form_type":"4"}},{"id":3303043,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-01-24T18:43:42.000Z","date":"2020-01-22","kind":"exercise","acquired":true,"shares":1250,"price":37.54,"value":46925.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."}],"balance_after":3271,"source":{"system":"sec-edgar","filing":"0001562180-20-000570","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/primarydocument.xml","form_type":"4"}},{"id":3303042,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-01-24T18:43:42.000Z","date":"2020-01-22","kind":"exercise","acquired":true,"shares":771,"price":32.42,"value":24995.82,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."}],"balance_after":2021,"source":{"system":"sec-edgar","filing":"0001562180-20-000570","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/primarydocument.xml","form_type":"4"}},{"id":3313695,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Unit Award","published_at":"2020-01-10T19:46:57.000Z","date":"2020-01-08","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents the contingent right to receive one common share of Biohaven Pharmaceutical Holding Co Ltd."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted 5,000 restricted share units on January 8, 2020, vesting in four equal installments on January 8, 2020, 2021, 2022 and 2023 subject to the reporting person's continued service with the issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This restricted stock unit is held by the reporting person's spouse as an employee of the issuer."}],"balance_after":3750,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001562180-20-000347","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/primarydocument.xml","form_type":"4"}},{"id":3313694,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Unit Award","published_at":"2020-01-10T19:46:57.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents the contingent right to receive one common share of Biohaven Pharmaceutical Holding Co Ltd."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted 5,000 restricted share units on January 8, 2020, vesting in four equal installments on January 8, 2020, 2021, 2022 and 2023 subject to the reporting person's continued service with the issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This restricted stock unit is held by the reporting person's spouse as an employee of the issuer."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-20-000347","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/primarydocument.xml","form_type":"4"}},{"id":3313693,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-10T19:46:57.000Z","date":"2020-01-09","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, representing a right to purchase a total of 30,000 shares was granted on December 15, 2016, vested in four equal installments on December 15, 2016, 2017, 2018 and 2019, subject to the optionholder's continuous service with the Issuer at each vesting date."}],"balance_after":0,"derivative":{"exercise_price":9.29,"expiration_date":"2026-12-14","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001562180-20-000347","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/primarydocument.xml","form_type":"4"}},{"id":3313692,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-01-10T19:46:57.000Z","date":"2020-01-08","kind":"exercise","acquired":true,"shares":1250,"price":55.91,"value":69887.5,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001562180-20-000347","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/primarydocument.xml","form_type":"4"}},{"id":3313691,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-01-10T19:46:57.000Z","date":"2020-01-09","kind":"sale","acquired":false,"shares":30000,"price":56.39,"value":1691700.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-000347","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/primarydocument.xml","form_type":"4"}},{"id":3313690,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-01-10T19:46:57.000Z","date":"2020-01-09","kind":"exercise","acquired":true,"shares":30000,"price":9.29,"value":278700.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001562180-20-000347","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/primarydocument.xml","form_type":"4"}},{"id":3333973,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-12-20T21:40:08.000Z","date":"2019-12-18","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option became exercisable with respect to 3,000 of the shares underlying the option on the grant date (December 18, 2019), and the remaining 9,000 shares underlying the option vest in three equal installments on December 18, 2020, 2021 and 2022, subject to the optionholder's continuous service with the issuer as of each applicable vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This stock option is held by the reporting person's spouse as an employee of the issuer."}],"balance_after":12000,"derivative":{"exercise_price":52.13,"expiration_date":"2029-12-18","underlying":"Common Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001689813-19-000130","document":"wf-form4_157689598816947.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000168981319000130/wf-form4_157689598816947.xml","form_type":"4"}},{"id":3337008,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-12-18T21:39:31.000Z","date":"2019-12-16","kind":"exercise","acquired":false,"shares":3537,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing a right to purchase a total of 30,436 shares was granted on December 7, 2017, vesting in four equal installments on December 7, 2018, 2019, 2020 and 2021, subject to the optionholder's continuous service with the Issuer at each vesting date. The optionholder previously exercised the option with respect to 7,609 shares on February 4, 2019 and 4,072 shares on December 9, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This employee stock option is held by the Reporting Person's spouse."}],"balance_after":15218,"derivative":{"exercise_price":20.79,"expiration_date":"2027-12-06","underlying":"Common Shares","underlying_shares":3537},"source":{"system":"sec-edgar","filing":"0001689813-19-000118","document":"wf-form4_157672315313106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/wf-form4_157672315313106.xml","form_type":"4"}},{"id":3337007,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-12-18T21:39:31.000Z","date":"2019-12-16","kind":"sale","acquired":false,"shares":3537,"price":55.1271,"value":194984.5527,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 - $55.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001689813-19-000118","document":"wf-form4_157672315313106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/wf-form4_157672315313106.xml","form_type":"4"}},{"id":3337006,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-12-18T21:39:31.000Z","date":"2019-12-16","kind":"exercise","acquired":true,"shares":3537,"price":20.79,"value":73534.23,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."}],"balance_after":3537,"source":{"system":"sec-edgar","filing":"0001689813-19-000118","document":"wf-form4_157672315313106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/wf-form4_157672315313106.xml","form_type":"4"}},{"id":3341083,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-17T02:03:49.000Z","date":"2019-12-12","kind":"grant","acquired":true,"shares":82878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in three annual installments after December 12, 2019, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":82878,"derivative":{"exercise_price":37.45,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":82878},"source":{"system":"sec-edgar","filing":"0000899243-19-029352","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924319029352/doc4.xml","form_type":"4"}},{"id":3345346,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-12-11T21:43:18.000Z","date":"2019-12-09","kind":"exercise","acquired":false,"shares":4072,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing a right to purchase a total of 30,436 shares was granted on December 7, 2017, vesting in four equal installments on December 7, 2018, 2019, 2020 and 2021, subject to the optionholder's continuous service with the Issuer at each vesting date.  The optionholder previously exercised the option with respect to 7,609 shares on February 4, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This employee stock option is held by the Reporting Person's spouse."}],"balance_after":18755,"derivative":{"exercise_price":20.79,"expiration_date":"2027-12-06","underlying":"Common Shares","underlying_shares":4072},"source":{"system":"sec-edgar","filing":"0001689813-19-000116","document":"wf-form4_157611858026350.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/wf-form4_157611858026350.xml","form_type":"4"}},{"id":3345345,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-12-11T21:43:18.000Z","date":"2019-12-09","kind":"sale","acquired":false,"shares":4072,"price":55.1107,"value":224410.7704,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 - $55.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001689813-19-000116","document":"wf-form4_157611858026350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/wf-form4_157611858026350.xml","form_type":"4"}},{"id":3345344,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-12-11T21:43:18.000Z","date":"2019-12-09","kind":"exercise","acquired":true,"shares":4072,"price":20.79,"value":84656.88,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."}],"balance_after":4072,"source":{"system":"sec-edgar","filing":"0001689813-19-000116","document":"wf-form4_157611858026350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/wf-form4_157611858026350.xml","form_type":"4"}},{"id":3361270,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-11-22T21:37:21.000Z","date":"2019-11-22","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, representing a right to purchase a total of 5,000 shares was granted on September 5, 2017, vesting in four equal installments on September 5, 2018, 2019, 2020 and 2021, subject to the Reporting Person's spouse continuous service with the issuer at each vesting date."}],"balance_after":3750,"derivative":{"exercise_price":37.54,"expiration_date":"2027-09-04","underlying":"Common Shares","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001689813-19-000097","document":"wf-form4_157447662358923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/wf-form4_157447662358923.xml","form_type":"4"}},{"id":3361269,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-11-22T21:37:21.000Z","date":"2019-11-20","kind":"exercise","acquired":false,"shares":6729,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing a right to purchase a total of 30,000 shares was granted on November 20, 2018, vesting in four equal installments on November 20, 2019, 2020, 2021 and 2022, subject to the Reporting Person's spouse continuous service with the issuer at each vesting date."}],"balance_after":23271,"derivative":{"exercise_price":32.42,"expiration_date":"2028-11-19","underlying":"Common Shares","underlying_shares":6729},"source":{"system":"sec-edgar","filing":"0001689813-19-000097","document":"wf-form4_157447662358923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/wf-form4_157447662358923.xml","form_type":"4"}},{"id":3361268,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-11-22T21:37:21.000Z","date":"2019-11-22","kind":"sale","acquired":false,"shares":1250,"price":55.24,"value":69050.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001689813-19-000097","document":"wf-form4_157447662358923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/wf-form4_157447662358923.xml","form_type":"4"}},{"id":3361267,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-11-22T21:37:21.000Z","date":"2019-11-22","kind":"exercise","acquired":true,"shares":1250,"price":37.54,"value":46925.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001689813-19-000097","document":"wf-form4_157447662358923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/wf-form4_157447662358923.xml","form_type":"4"}},{"id":3361266,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-11-22T21:37:21.000Z","date":"2019-11-20","kind":"sale","acquired":false,"shares":6729,"price":52.1971,"value":351234.2859,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.31 - $53.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001689813-19-000097","document":"wf-form4_157447662358923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/wf-form4_157447662358923.xml","form_type":"4"}},{"id":3361265,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-11-22T21:37:21.000Z","date":"2019-11-20","kind":"exercise","acquired":true,"shares":6729,"price":32.42,"value":218154.18,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."}],"balance_after":6729,"source":{"system":"sec-edgar","filing":"0001689813-19-000097","document":"wf-form4_157447662358923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/wf-form4_157447662358923.xml","form_type":"4"}},{"id":3415095,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-09-13T16:34:52.000Z","date":"2019-09-11","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, representing a right to purchase a total of 40,000 shares was granted on August 4, 2017, vesting in four equal installments on July 5, 2018, 2019, 2020 and 2021, subject to the optionholder's continuous service with the Issuer at each vesting date. The optionholder previously exercised the option with respect to 10,000 shares on February 4, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This employee stock option is held by the Reporting Person's spouse."}],"balance_after":20000,"derivative":{"exercise_price":25.51,"expiration_date":"2027-08-03","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001689813-19-000063","document":"wf-form4_156840679456814.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/wf-form4_156840679456814.xml","form_type":"4"}},{"id":3415094,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-09-13T16:34:52.000Z","date":"2019-09-11","kind":"sale","acquired":false,"shares":10000,"price":45,"value":450000.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001689813-19-000063","document":"wf-form4_156840679456814.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/wf-form4_156840679456814.xml","form_type":"4"}},{"id":3415093,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-09-13T16:34:52.000Z","date":"2019-09-11","kind":"exercise","acquired":true,"shares":10000,"price":25.51,"value":255100.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001689813-19-000063","document":"wf-form4_156840679456814.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/wf-form4_156840679456814.xml","form_type":"4"}},{"id":3465942,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-08T21:29:36.000Z","date":"2019-07-03","kind":"purchase","acquired":true,"shares":882353,"price":29.9005,"value":26382795.8765,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned by BridgeBio Pharma LLC. The Reporting Person is a member of the board of managers of BridgeBio Pharma LLC and may be deemed to beneficially own the shares held by BridgeBio Pharma LLC. The Reporting Person disclaims beneficial ownership of the shares for Section 16 purposes or for any other purpose, except to the extent of his pecuniary interest therein."}],"balance_after":24575501,"source":{"system":"sec-edgar","filing":"0000899243-19-019339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319019339/doc4.xml","form_type":"4"}},{"id":3491498,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-13T21:27:23.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":21528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in a single installment on the earlier of (i) the first anniversary of the grant date, so that all of the underlying shares shall be vested on June 12, 2020, or (ii) the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service with the Issuer through the vesting date.  This option is subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2018 Stock Option and Incentive Plan, as amended)."}],"balance_after":21528,"derivative":{"exercise_price":30.87,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":21528},"source":{"system":"sec-edgar","filing":"0000899243-19-016956","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319016956/doc4.xml","form_type":"4"}},{"id":3508992,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-29T19:13:57.000Z","date":"2019-05-24","kind":"purchase","acquired":true,"shares":1103848,"price":25.93,"value":28622778.64,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned by BridgeBio Pharma LLC. The Reporting Person is a member of the board of managers of BridgeBio Pharma LLC and may be deemed to beneficially own the shares held by BridgeBio Pharma LLC. The Reporting Person disclaims beneficial ownership of the shares for Section 16 purposes or for any other purpose, except to the extent of his pecuniary interest therein."}],"balance_after":23693148,"source":{"system":"sec-edgar","filing":"0000899243-19-015089","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924319015089/doc4.xml","form_type":"4"}},{"id":3513551,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-23T18:34:29.000Z","date":"2019-05-21","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 21, 2020 or (b) the date of the 2020 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":18000,"derivative":{"exercise_price":61.76,"expiration_date":"2029-05-20","underlying":"Common Shares","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-19-032465","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000120919119032465/doc4.xml","form_type":"4"}},{"id":3537885,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-06T23:09:24.000Z","date":"2019-05-02","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve equal monthly installments starting from May 2, 2019."}],"balance_after":10000,"derivative":{"exercise_price":24.16,"expiration_date":"2029-05-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-19-012319","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924319012319/doc4.xml","form_type":"4"}},{"id":3656806,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-14T16:30:04.000Z","date":"2018-11-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in four equal installments on November 20, 2019, 2020, 2021 and 2022, subject to the reporting person's spouse continuous service with the issuer at each vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This stock option is held by the reporting person's spouse as an employee of the issuer."}],"balance_after":30000,"derivative":{"exercise_price":32.42,"expiration_date":"2028-11-19","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-010166","document":"doc5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000120919119010166/doc5.xml","form_type":"5"}},{"id":3672349,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-06T18:21:52.000Z","date":"2019-02-04","kind":"exercise","acquired":false,"shares":7609,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option vest in four equal installments on December 7, 2018, 2019, 2020 and 2021, subject to the optionholder's continuous service with the Issuer at each vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This employee stock option is held by the Reporting Person's spouse."}],"balance_after":22827,"derivative":{"exercise_price":20.79,"expiration_date":"2027-12-06","underlying":"Common Shares","underlying_shares":7609},"source":{"system":"sec-edgar","filing":"0001209191-19-007869","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/doc4.xml","form_type":"4"}},{"id":3672348,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-06T18:21:52.000Z","date":"2019-02-04","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in four equal installments on July 5, 2018, 2019, 2020 and 2021, subject to the optionholder's continuous service with the Issuer at each vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This employee stock option is held by the Reporting Person's spouse."}],"balance_after":30000,"derivative":{"exercise_price":25.51,"expiration_date":"2027-08-03","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-007869","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/doc4.xml","form_type":"4"}},{"id":3672347,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-02-06T18:21:52.000Z","date":"2019-02-04","kind":"exercise","acquired":false,"shares":17609,"price":42.54,"value":749086.86,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.54 - $42.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-007869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/doc4.xml","form_type":"4"}},{"id":3672346,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-02-06T18:21:52.000Z","date":"2019-02-04","kind":"exercise","acquired":true,"shares":7609,"price":20.79,"value":158191.11,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."}],"balance_after":17609,"source":{"system":"sec-edgar","filing":"0001209191-19-007869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/doc4.xml","form_type":"4"}},{"id":3672345,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-02-06T18:21:52.000Z","date":"2019-02-04","kind":"exercise","acquired":true,"shares":10000,"price":25.51,"value":255100.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-19-007869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/doc4.xml","form_type":"4"}},{"id":3750217,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-29T00:17:14.000Z","date":"2018-11-27","kind":"sale","acquired":false,"shares":10000,"price":13.5,"value":135000.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-18-029769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924318029769/doc4.xml","form_type":"4"}},{"id":3875680,"issuer":{"id":143355,"kind":"organization","name":"Eidos Therapeutics, Inc.","symbol":"EIDX"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-03T19:05:18.000Z","date":"2018-07-01","kind":"grant","acquired":true,"shares":43056,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person is a participant in the Issuer's 2018 Stock Option and Incentive Plan and received 43,056 stock options (the \"Grant\") on July 2, 2018.  The Grant shall vest as follows: one-third of the stock options shall vest annually over a period of three (3) years following June 29, 2018 subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":43056,"derivative":{"exercise_price":20.34,"expiration_date":"2028-06-30","underlying":"Common Stock","underlying_shares":43056},"source":{"system":"sec-edgar","filing":"0000899243-18-019331","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731831/000089924318019331/doc4.xml","form_type":"4"}},{"id":3883934,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-06-26T00:39:21.000Z","date":"2018-06-22","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve equal monthly installments starting from June 22, 2018."}],"balance_after":10000,"derivative":{"exercise_price":8.08,"expiration_date":"2028-06-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-18-018002","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924318018002/doc4.xml","form_type":"4"}},{"id":3947656,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-03T17:20:33.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 1, 2019 or (b) the date of the 2019 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":18000,"derivative":{"exercise_price":28.76,"expiration_date":"2028-04-30","underlying":"Common Shares","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-18-027716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000120919118027716/doc4.xml","form_type":"4"}},{"id":4136599,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-12-11T17:31:52.000Z","date":"2017-12-07","kind":"grant","acquired":true,"shares":30436,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in four equal installments on December 7, 2018, 2019, 2020 and 2021, subject to the optionholder's continuous service with the issuer at each vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This employee stock option is held by the reporting person's spouse."}],"balance_after":30436,"derivative":{"exercise_price":20.79,"expiration_date":"2027-12-06","underlying":"Common Shares","underlying_shares":30436},"source":{"system":"sec-edgar","filing":"0001209191-17-065056","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000120919117065056/doc4.xml","form_type":"4"}},{"id":4211790,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-09-12T18:24:15.000Z","date":"2017-09-05","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in four equal installments on September 5, 2018, 2019, 2020 and 2021, subject to the optionholder's continuous service with the issuer at each vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This employee stock option is held by the reporting person's spouse."}],"balance_after":5000,"derivative":{"exercise_price":37.54,"expiration_date":"2027-09-04","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-17-052486","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000120919117052486/doc4.xml","form_type":"4"}},{"id":4240195,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-08-08T16:03:05.000Z","date":"2017-08-04","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in four equal installments on July 5, 2018, 2019, 2020 and 2021, subject to the optionholder's continuous service with the issuer at each vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This employee stock option is held by the reporting person's spouse."}],"balance_after":40000,"derivative":{"exercise_price":25.51,"expiration_date":"2027-08-03","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-17-048076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689813/000120919117048076/doc4.xml","form_type":"4"}},{"id":4333132,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-04T20:09:16.000Z","date":"2017-05-02","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve equal monthly installments beginning on May 2, 2017."}],"balance_after":10000,"derivative":{"exercise_price":11.13,"expiration_date":"2027-05-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-17-011813","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924317011813/doc4.xml","form_type":"4"}},{"id":4546923,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":35665,"kind":"person","name":"AGUIAR ERIC","position":1,"cik":"0001262325","reported_name":"AGUIAR ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-21T23:29:39.000Z","date":"2016-11-18","kind":"purchase","acquired":true,"shares":10000,"price":6.2834,"value":62834.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a weighted average purchase price for multiple transactions at prices ranging from $6.25 to $6.30, inclusive. Upon request by the Commission staff, the Company or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased by the reporting person on November 18, 2016 at each separate price."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-16-034048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262325/000089924316034048/doc4.xml","form_type":"4"}}]}